Clinical Trial Looks at Targeted Genetic Therapies for Lung Cancer

Clinical Trial Looks at Targeted Genetic Therapies for Lung Cancer Researchers at UC are enrolling patients in a clinical trial looking attargeted gene therapies in patients with early stage lung cancer who have hadsurgery.


Researchers Discover New Combination Brain, Blood Cancer Therapy Strategy

Researchers at the University of Cincinnati (UC) College of Medicine havediscovered a new potential strategy to personalize therapy for brain and bloodcancers.


Cancer Clinical Trials Office Recognized by National Network

The UC Cancer Institute's Clinical Trials Office has been selected to receivefinancial support from the NCI's National Clinical Trials Network for beinghigh performing.


GIVEHOPE, BSI Engineering Provide Support for Pancreatic Cancer Research

Thanks to funding support from GIVEHOPE and BSI Engineering, Inc., scientistsat UC can continue research that could help better treat pancreatic cancerpatients.


Researcher Receives Leukemia and Lymphoma Society Scholar Award

Jianjun Chen, PhD, received a $550,000 Leukemia and Lymphoma Society ScholarAward to support research looking at the role of TET1 protein in acute myeloidleukemia.


Free Pancreatic Cancer Symposium Feb. 18 Provides Info on Latest Research

The UC Cancer Institute is hosting a free educational event surroundingpancreatic cancer for patients, survivors, their families and the community.


Patient Beats Pancreatic Cancer Diagnosis With Help From UC Team

To say Ft. Mitchell, Kentucky resident Doug Lange, 63, is always on the go isan understatement.


Kentucky Resident Back to Living Life to the Fullest After Proton Therapy

Troy Witt, 65, a London, Kentucky resident, completed treatment at theCincinnati Children's/UC Health Proton Therapy Center in Fall 2016. Now, he'sback to enjoying life.